Mary-Ellen Taplin, MD
Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Dr. Mary-Ellen Taplin is Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School, Director of Clinical Research for the Dana-Farber Lank Center of Genitourinary Oncology and Chairperson of the DFCI Executive Committee for Clinical Research. Dr. Taplin is an expert genitourinary clinician and a mentor to many junior investigators. She serves as lead investigator on many projects including the Prostate Cancer Clinical Trials Consortium, Dana-Farber SPORE grant, Stand Up 2 Cancer and several Prostate Cancer Foundation Challenge Grants.
Dr. Taplin is dedicated to clinical and translational investigations that focus on novel approaches to treat localized high-risk prostate cancer and secondary hormone therapy for metastatic castration-resistant prostate cancer. Her research has described molecular and physiologic alterations in the androgen receptor pathway in the context of prostate cancer resistance.